CCL4L polymorphisms and CCL4/CCL4L serum levels are associated with psoriasis severity

Journal of Investigative Dermatology

Volumn 131, Issue 9, 2011, Pages 1830-1837

  Pedrosa, Edurne ^a,b   Carretero Iglesia, Laura ^c   Boada, Aram ^d   Colobran, Roger ^a   Faner, Rosa ^e   Pujol Autonell, Irma ^a,b   Palou, Eduard ^a   Esteve, Anna ^f   Pujol Borrell, Ricardo ^a,b   Ferrándiz, Carlos ^d   Juan, Manel ^c   Carrascosa, José Manuel ^d  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f Centre d'Estudis Epidemiològics sobre la Sida a Catalunya CEESCAT Badalona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CCL1 CHEMOKINE; CHEMOKINE; CHEMOKINE CCL4L; CHEMOKINE CCL4L2; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; RETINOID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; COPY NUMBER VARIATION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PSORIASIS; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 80955180090     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.127     Document Type: Article

References (41)

1. Cargill M, Schrodi SJ, Chang M et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273-90 (Pubitemid 46175676)
2. Carvalho CM, Zhang F, Lupski JR (2010) Evolution in health and medicine Sackler colloquium: Genomic disorders: a window into human gene and genome evolution. Proc Natl Acad Sci USA 107(Suppl 1):1765-71
3. Colobran R, Adreani P, Ashhab Y et al. (2005) Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients. J Immunol 174:5655-64 (Pubitemid 40593207)
4. Colobran R, Casamitjana N, Roman A et al. (2009) Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. Genes Immun 10:254-9
5. Colobran R, Comas D, Faner R et al. (2008) Population structure in copy number variation and SNPs in the CCL4L chemokine gene. Genes Immun 9:279-88 (Pubitemid 351791482)
6. Colobran R, Pedrosa E, Carretero-Iglesia L et al. (2010) Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clin Exp Immunol 162:41-52
7. de Cid R, Riveira-Munoz E, Zeeuwen PL et al. (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41:211-5
8. Elder JT, Bruce AT, Gudjonsson JE et al. (2009) Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 130:1213-26
9. Ferrándiz C, Pujol RM, Garcia-Patos V et al. (2002) Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 46:867-73
10. Gudjonsson JE, Ding J, Johnston A et al. (2010) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130:1829-40
11. Hollox EJ, Huffmeier U, Zeeuwen PL et al. (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40:23-5
12. Howard OM, Turpin JA, Goldman R et al. (2004) Functional redundancy of the human CCL4 and CCL4L1 chemokine genes. Biochem Biophys Res Commun 320:927-31 (Pubitemid 38887232)
13. Huffmeier U, Bergboer JG, Becker T et al. (2010) Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. J Invest Dermatol 130:979-84
14. Kagami S, Rizzo HL, Lee JJ et al. (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373-83
15. Krueger JG, Bowcock A (2005) Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 64(Suppl 2):ii30-6 (Pubitemid 40288517)
16. Krueger JG, Wolfe JT, Nabeya RT et al. (1995) Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182:2057-68
17. Lonsdorf AS, Hwang ST, Enk AH (2009) Chemokine receptors in T-cell-mediated diseases of the skin. J Invest Dermatol 129:2552-66
18. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73
19. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-11 (Pubitemid 351543220)
20. Luther SA, Cyster JG (2001) Chemokines as regulators of T cell differentiation. Nat Immunol 2:102-7 (Pubitemid 33707926)
21. Melzer D, Perry JR, Hernandez D et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4:e1000072
22. Menten P, Wuyts A, Van Damme J (2002) Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13:455-81 (Pubitemid 35303816)
23. Modi WS, Bergeron J, Sanford M (2001) The human MIP-1beta chemokine is encoded by two paralogous genes, ACT-2 and LAG-1. Immunogenetics 53:543-9 (Pubitemid 33044433)
24. Mulloy B, Rider CC (2006) Cytokines and proteoglycans: an introductory overview. Biochem Soc Trans 34:409-13 (Pubitemid 43953999)
25. Nair RP, Duffin KC, Helms C et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41:199-204
26. Nair RP, Stuart PE, Nistor I et al. (2006) Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78:827-51
27. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
28. Nickoloff BJ, Xin H, Nestle FO et al. (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25:568-73 (Pubitemid 350103656)
29. Nomura I, Gao B, Boguniewicz M et al. (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112:1195-202 (Pubitemid 37550015)
30. Olson TS, Ley K (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283:R7-28 (Pubitemid 34863907)
31. Pastore S, Mascia F, Mariotti F et al. (2004) Chemokine networks in inflammatory skin diseases. Eur J Dermatol 14:203-8 (Pubitemid 39024223)
32. Puig L, Carrascosa JM, Dauden E et al. (2009) [Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]. Actas Dermosifiliogr 100:386-413
33. Redon R, Ishikawa S, Fitch KR et al. (2006) Global variation in copy number in the human genome. Nature 444:444-54 (Pubitemid 44809057)
34. Schaschl H, Aitman TJ, Vyse TJ (2009) Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol 156:12-6
35. Schon MP, Ruzicka T (2001) Psoriasis: the plot thickens. Nat Immunol 2:91
36. Shostakovich-Koretskaya L, Catano G, Chykarenko ZA et al. (2009) Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS 23:679-88
37. Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-45
38. Townson JR, Barcellos LF, Nibbs RJ (2002) Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol 32:3016-26 (Pubitemid 35238195)
39. Willcocks LC, Lyons PA, Clatworthy MR et al. (2008) Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 205:1573-82 (Pubitemid 351962021)
40. Yan KX, Fang X, Han L et al. (2010) Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque versus guttate psoriasis vulgaris. Br J Dermatol 163:48-56
41. Zhang L, Yang XQ, Cheng J et al. (2010) Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. Clin Immunol 135:108-17